Department of Information Engineering, Università Politecnica delle Marche, Ancona, Italy.
Department of Information Engineering, Università Politecnica delle Marche, Ancona, Italy.
J Electrocardiol. 2021 Nov-Dec;69S:55-60. doi: 10.1016/j.jelectrocard.2021.10.005. Epub 2021 Oct 24.
Drug-induced block of the hERG potassium channel could predispose to torsade de pointes, depending on occurrence of concomitant blocks of the calcium and/or sodium channels. Since the hERG potassium channel block affects cardiac repolarization, the aim of this study was to propose a new reliable index for non-invasive assessment of drug-induced hERG potassium channel block based on electrocardiographic T-wave features.
ERD (early repolarization duration) and T (down-going T-wave slope to T-wave amplitude ratio) features were measured in 22 healthy subjects who received, in different days, doses of dofetilide, ranolazine, verapamil and quinidine (all being hERG potassium channel blockers and the latter three being also blockers of calcium and/or sodium channels) while undergoing continuous electrocardiographic acquisition from which ERD and T were evaluated in fifteen time points during the 24 h following drug administration ("ECG Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects" database by Physionet). A total of 1320 pairs of ERD and T measurements, divided in training (50%) and testing (50%) datasets, were obtained. Drug-induced hERG potassium channel block was modelled by the regression equation B(%) = a·ERD + b·T+ c·ERD·T + d; B(%) values were compared to plasma-based measurements, B(%).
Regression coefficients values, obtained on the training dataset, were: a = -561.0 s, b = -9.7 s, c = 77.2 and d = 138.9. In the testing dataset, correlation coefficient between B(%) and B(%) was 0.67 (p < 10); estimation error was -11.5 ± 16.7%.
B(%) is a reliable non-invasive index for the assessment of drug-induced hERG potassium channel block, independently from concomitant blocks of other ions.
药物诱导的 hERG 钾通道阻滞可导致尖端扭转型室性心动过速,这取决于同时发生的钙和/或钠通道阻滞。由于 hERG 钾通道阻滞会影响心脏复极,因此本研究旨在提出一种新的可靠指标,用于基于心电图 T 波特征对药物诱导的 hERG 钾通道阻滞进行非侵入性评估。
在 22 名健康受试者中测量 ERD(早期复极持续时间)和 T(下传 T 波斜率与 T 波幅度比值)特征,这些受试者在不同的日子里接受了多非利特、雷诺嗪、维拉帕米和奎尼丁(均为 hERG 钾通道阻滞剂,后三者也是钙和/或钠通道阻滞剂)的剂量,同时进行连续心电图采集,在给药后 24 小时内的 15 个时间点评估 ERD 和 T(由 Physionet 提供的“雷诺嗪、多非利特、维拉帕米和奎尼丁对健康受试者心电图影响”数据库)。共获得 1320 对 ERD 和 T 测量值,分为训练(50%)和测试(50%)数据集。药物诱导的 hERG 钾通道阻滞通过回归方程 B(%)= a·ERD+b·T+c·ERD·T+d 进行建模;将 B(%)值与基于血浆的测量值 B(%)进行比较。
在训练数据集上获得的回归系数值为:a=-561.0 s,b=-9.7 s,c=77.2,d=138.9。在测试数据集中,B(%)与 B(%)之间的相关系数为 0.67(p<10);估计误差为-11.5±16.7%。
B(%)是评估药物诱导的 hERG 钾通道阻滞的一种可靠的非侵入性指标,与其他离子的同时阻滞无关。